Abstract |
Clinical trials indicate that sodium/ glucose co-transporter 2 ( SGLT2) inhibitors (SGLT2i) improve kidney function, yet, the molecular regulation of SGLT2 expression is incompletely understood. Here, we investigated the role of the intrarenal renin-angiotensin system (RAS) on SGLT2 expression. In adult non-diabetic participants in the Nephrotic Syndrome Study Network (NEPTUNE, n=163), multivariable linear regression analysis showed SGLT2 mRNA was significantly associated with angiotensinogen (AGT), renin, and angiotensin-converting enzyme (ACE) mRNA levels (P<0.001). In vitro, angiotensin II (Ang II) dose-dependently stimulated SGLT2 expression in HK-2, human immortalized renal proximal tubular cells (RPTCs); losartan and antioxidants inhibited it. Sglt2 expression was increased in transgenic (Tg) mice specifically overexpressing Agt in their RPTCs, as well as in WT mice with a single subcutaneous injection of Ang II (1.44 mg/kg). Moreover, Ang II (1000 ng/kg/min) infusion via osmotic mini-pump in WT mice for 4 weeks increased systolic blood pressure (SBP), glomerulosclerosis, tubulointerstitial fibrosis, and albuminuria; canaglifozin (Cana, 15 mg/kg/day) reversed these changes, with the exception of SBP. Fractional glucose excretion (FeGlu) was higher in Ang II+Cana than WT+Cana, whereas Sglt2 expression was similar. Our data demonstrate a link between intrarenal RAS and SGLT2 expression and that SGLT2i ameliorates Ang II-induced renal injury independent of SBP.
|
Authors | Kana N Miyata, Chao-Sheng Lo, Shuiling Zhao, Min-Chun Liao, Yuchao Pang, Shiao-Ying Chang, Junzheng Peng, Matthias Kretzler, Janos G Filep, Julie R Ingelfinger, Shao-Ling Zhang, John S D Chan |
Journal | Clinical science (London, England : 1979)
(Clin Sci (Lond))
Vol. 135
Issue 7
Pg. 943-961
(04 16 2021)
ISSN: 1470-8736 [Electronic] England |
PMID | 33822013
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society. |
Chemical References |
- Sodium-Glucose Transporter 2
- Sodium-Glucose Transporter 2 Inhibitors
- Angiotensin II
|
Topics |
- Adult
- Angiotensin II
(pharmacology)
- Animals
- Cell Line
- Female
- Humans
- Hypertension
(chemically induced)
- Kidney Diseases
(physiopathology)
- Male
- Mice
- Mice, Transgenic
- Middle Aged
- Renin-Angiotensin System
(drug effects)
- Sodium-Glucose Transporter 2
(genetics, metabolism)
- Sodium-Glucose Transporter 2 Inhibitors
(pharmacology)
|